MK0524B

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0524B, covering 2010-01-06 to 2010-01-06. Get the full timeline:

Most recent: Clinical Trial Update: MK0524B Bioequivalence Study (0524B-070) [Phase 1]